PK Submit CDISC Technology
PK Submit automates the time consuming, error-prone and complex task of creating CDISC domains as…
CertaraMarch 10, 2021
PBPK modeling supports approval of breakthrough cancer drug
Pharmacyclics’ (now AbbVie) Imbruvica (ibrutinib) is an anticancer drug targeting B-cell malignancies. Leveraging the US…
CertaraOctober 23, 2020
